Search ResultsElectronic Resources 
by
Abou-Fadel, Johnathan Salim, author.
Format:
Excerpt:
of ligase enzymes in this pathway for development of novel therapeutics capable of targeting the
by
Drufva, Erin, author. (orcid)0000-0001-6497-9949
Format:
Excerpt:
diverse applications including biosynthesis, biocatalysis, therapeutics, drug delivery, and bioremediation
by
Apoorva, author. (orcid)0000-0001-9357-0173
Format:
Excerpt:
class of therapeutics.
by
Garcia, Luis Daniel Borrero, author.
Format:
Excerpt:
different concentrations of the EGFR1 and HER2 targeted therapeutics gefitinib (Gef) and lapatinib (Lap
by
Caneus, Julbert, author.
Format:
Excerpt:
will establish a strong foundation for the development of novel preventative therapeutics.
by
Negrón Abril, Yashira L., author.
Format:
Excerpt:
, we tested SIRT5-selective small molecule inhibitors as cancer therapeutics. Pharmacological
by
Mingle, Kathleen B., author.
Format:
Excerpt:
AuNP therapeutics. Additionally, the experimental efforts of the project collaborators led to an
by
Eberle-Singh, Jaime, author.
Format:
Excerpt:
Therapeutics as a post-translational inhibitor of BMI1. Treatment with PTC596 leads to hyperphosphorylated BMI1
by
Schroeder, Laura Elizabeth, author.
Format:
Excerpt:
will first be required for development of better therapeutics.
by
Rezaei, Nima.
Format:
Excerpt:
-- DESIGNING CLINICAL TRIALS -- REFERENCES -- 13 - COMBINATION THERAPY: CANCER VACCINES AND OTHER THERAPEUTICS
by
Gosavi, Pallavi M., author.
Format:
Excerpt:
, antibody therapeutics and drug delivery applications etc. In this work, we used a minimalistic approach
by
Bhatia, Hemlata, author.
Format:
Excerpt:
in nearly 70% of the manufactured recombinant therapeutics with the current sales of over $30 billion

Select an Action





